Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News AYP-101 could replace Kybella? AMI Pharm’s injectable shows strong Phase 2 results for fat reduction AMI Pharm's AYP-101 delivers strong Phase 2 results in reducing submental fat—find out why it’s being called a game-changer in nonsurgical aesthetics. byPallavi MadhirajuSeptember 1, 2025